Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Osprey Medical on investors' radars  Join our daily free Newsletter

MENAFN - ProactiveInvestors - Australia - 04/11/2012

No. of Ratings : 0
Add to Mixx!


 


(MENAFN - ProactiveInvestors - Australia) Osprey Medical (ASX: OSP) has sparked some investor interest today with an almost 12% increase in its share price to an intra-day high of A0.38.

The company has regained some ground in recent weeks since trading at a low of 0.31 in late September.

Osprey is making substantial progress in getting its lead product, the CINCOR„ System, for the prevention of kidney damage to market.

Commercialisation is targeted for 2012. Indicating the potential revenues that can be achieved, the U.S. and western Europe addressable market represents between US600 and 800 million per annum.

Osprey already has CE Mark approval for the CINCOR„ System.

The CINCOR„ System reduces and removes a significant quantity of dye used to x-ray heart tissue during angioplasty, but can cause serious and irreversible damage to the kidneys.

Currently there is no good way of preventing dye from reaching the kidneys.

Osprey revealed earlier this week enhancements to the system that reduces the amount of x-ray dye that is used during common heart procedures.

Reducing the amount of dye, in addition to capturing and removing the dye that is used, is expected to protect the kidney from dye exposure and reduce the incidence of contrast induced nephropathy (CIN).

The new dye reduction system has been successfully used on 44 patients, including 14 at Melbourne's Baker IDI Heart and Diabetes Institute.

Following successful clinical trials across six sites in Australia, New Zealand and Europe, Osprey obtained CE Mark and plans to begin a controlled market launch of the CINCOR„ System in Europe in 2012.

The company has also obtained approval from the U.S. Food and Drug Administration (FDA) to conduct a registration-directed pivotal trial, which is planned for 2012.

Osprey is targeting FDA approval to enable a U.S. market launch of the CINCOR„ System in 2014.

 






  MENA News Headlines


 
Live Currency Rates






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help